
Siemens Healthineers, which sells products and solutions for the prevention, diagnosing, treatment and monitoring of diseases, has upgraded its mid-term guidance, Bloomberg News reports ahead of the company's capital markets day, referring to a press release.
Following the news, Siemens Healthineers' stock price went up 3.5 percent, trading at EUR 62.52.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app